[1]
E. Heinzelmann, “High Added Value – but Many Stumbling Blocks along the Way NTN Biotech Identifies where the Shoe Pinches: Biotechnet Switzerland”, Chimia, vol. 70, no. 1-2, p. 118, Feb. 2016.